Disease caused by atypical mycobacteria frequently mimics that due to M. tuberculosis, yet the chemotherapeutic response and prognosis differ markedly. Differentiation is thus a key problem. Although awareness of the atypical forms dates back to the last century, only in the past 15 years has progress been made in establishing the pathogenicity of the atypical forms and in methods of identifying and classifying them.